Amanta Healthcare IPO GMP History
Amanta Healthcare IPO has been listed on September 9, 2025 at a listing price of ₹135, against the issue price of ₹126 — a gain of ₹9 (+7.14%). The GMP peaked at ₹18 on 29 August 2025 and reached a low of ₹7 on 3 September 2025. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Amanta Healthcare IPO raised ₹126 Cr. through its IPO at a price band of ₹120 to ₹126 per share, with a lot size of 119 shares. The IPO was open for subscription from 01 Sep 2025 to 03 Sep 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 1:05 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 06 Sep 2025 | ₹ 8 | ▲ | 6% | — | — |
| 03 Sep 2025 | ₹ 7 | ▼ | 6% | — | — |
| 02 Sep 2025 | ₹ 12 | ▼ | 10% | — | — |
| 29 Aug 2025 | ₹ 18 | ▲ | 14% | — | — |
| 25 Aug 2025 | ₹ 16 | — | 13% | — | — |
Amanta Healthcare IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 01 Sep 2025
- Close 03 Sep 2025
- Allotment 04 Sep 2025
- Refund/credit 08 Sep 2025
- Listing 09 Sep 2025
Amanta Healthcare IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹126 |
|---|---|
| GMP-based estimate (pre-listing) | ₹134 (+6.3%) |
| Listing gain / loss | +₹9 per share |
| Listing date | 09 Sep, 2025 |
| Actual listing price | ₹135 (+7.14%) |
Is Amanta Healthcare IPO GMP reliable?
Grey market premium for Amanta Healthcare IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Amanta Healthcare IPO full review for a fundamentals-based assessment before making any grey market trades.
Amanta Healthcare IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Amanta Healthcare IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Amanta Healthcare IPO
Amanta Healthcare Limited was incorporated in December 1994. It develops, makes and markets sterile liquid products, mainly parenteral products packed in plastic containers. It also makes medical devices.
The range includes IV fluids, diluents, ophthalmic solutions and respiratory care products. In medical devices it offers irrigation solutions, first-aid products and eye lubricants.
The company sells through three business units: national sales, international sales and product partnering.
The IPO was a fresh issue of Rs 126 crore. Rs 70.00 crore and Rs 30.13 crore were planned for two civil construction and machinery projects.
Frequently asked
What is the GMP of Amanta Healthcare IPO?
The current Grey Market Premium (GMP) of Amanta Healthcare IPO is ₹ 8.
What is the Kostak Price of Amanta Healthcare IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Amanta Healthcare IPO is not available.
What is the Subject to Sauda Price of Amanta Healthcare IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Amanta Healthcare IPO?
Amanta Healthcare IPO listed on September 9, 2025 at ₹135, against the issue price of ₹126 — a gain of +7.14%.
How did the GMP of Amanta Healthcare IPO trend before listing?
The GMP of Amanta Healthcare IPO was rising in its final days before listing. The GMP peaked at ₹18 on 29 August 2025. View the day-wise table above for the complete GMP history.
Explore Amanta Healthcare IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
